ATE319997T1 - Screeningverfahren für modulatoren von integrinen - Google Patents
Screeningverfahren für modulatoren von integrinenInfo
- Publication number
- ATE319997T1 ATE319997T1 AT01402843T AT01402843T ATE319997T1 AT E319997 T1 ATE319997 T1 AT E319997T1 AT 01402843 T AT01402843 T AT 01402843T AT 01402843 T AT01402843 T AT 01402843T AT E319997 T1 ATE319997 T1 AT E319997T1
- Authority
- AT
- Austria
- Prior art keywords
- integrins
- modulators
- screening process
- methods
- beta
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 108010044426 integrins Proteins 0.000 title abstract 2
- 102000006495 integrins Human genes 0.000 title abstract 2
- 238000012216 screening Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 108010042442 integrin alphaEbeta7 Proteins 0.000 abstract 1
- 108010021315 integrin beta7 Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Optical Communication System (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01402843A EP1308726B1 (de) | 2001-11-05 | 2001-11-05 | Screeningverfahren für Modulatoren von Integrinen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE319997T1 true ATE319997T1 (de) | 2006-03-15 |
Family
ID=8182955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01402843T ATE319997T1 (de) | 2001-11-05 | 2001-11-05 | Screeningverfahren für modulatoren von integrinen |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1308726B1 (de) |
| AT (1) | ATE319997T1 (de) |
| DE (1) | DE60117743T2 (de) |
| ES (1) | ES2257388T3 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4441537B2 (ja) * | 2003-11-29 | 2010-03-31 | プロテオゲン インコーポレイテッド | インテグリン拮抗物質の超高速大量探索方法及びそれによる新規ペプチド |
| WO2007007151A2 (en) * | 2005-07-11 | 2007-01-18 | Pfizer Limited | Use of anti-mad-cam antibody for the treatment of emphysema |
| WO2011103049A2 (en) * | 2010-02-16 | 2011-08-25 | Immune Disease Institute, Inc. | Method for screening receptors/ligands interactions |
| DE102017114537A1 (de) * | 2017-06-29 | 2019-01-03 | Endress+Hauser Conducta Gmbh+Co. Kg | Sensormembran, Sensorkappe und optischer Sensor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5837478A (en) * | 1993-12-23 | 1998-11-17 | Icos Corporation | Method of identifying modulators of binding between and VCAM-1 |
| CA2224571A1 (en) * | 1996-04-15 | 1997-10-23 | Icos Corporation | Cytoplasmic modulators of integrin regulation/signaling |
| WO1999058573A1 (en) * | 1998-05-13 | 1999-11-18 | Genentech, Inc. | Diagnosis and treatment of hepatic disorders |
-
2001
- 2001-11-05 ES ES01402843T patent/ES2257388T3/es not_active Expired - Lifetime
- 2001-11-05 EP EP01402843A patent/EP1308726B1/de not_active Expired - Lifetime
- 2001-11-05 DE DE60117743T patent/DE60117743T2/de not_active Expired - Fee Related
- 2001-11-05 AT AT01402843T patent/ATE319997T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1308726B1 (de) | 2006-03-08 |
| EP1308726A1 (de) | 2003-05-07 |
| ES2257388T3 (es) | 2006-08-01 |
| DE60117743T2 (de) | 2006-10-12 |
| DE60117743D1 (de) | 2006-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69630214D1 (de) | Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien | |
| DE69527987D1 (de) | Formulierungen und verfahren zur reduzierung von hautreizung | |
| TR200100267T2 (tr) | İkameli anilid bileşimleri ve yöntemler. | |
| CY1108860T1 (el) | Θραυσματα αυξητικου παραγοντα συνδετικου ιστου και μεθοδοι και χρησεις τους | |
| EP0723398A4 (de) | Superoxiddismutase und ihre memetika | |
| CY1105836T1 (el) | 12, 13-τροποποιημενα παραγωγα εποθιλονης | |
| PT1140944E (pt) | Derivados de epotilona e sua utilizacao como agentes antitumorais | |
| ATE319823T1 (de) | Bmp-12, bmp-13 und diese enthaltende sehne- induzierende zusammensetzungen | |
| ATE225176T1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
| AR038563A1 (es) | Composicion de ziprasidona y controles sinteticos | |
| EP1409544A4 (de) | Humane dr4-antikörper und deren anwendungen | |
| PT1017659E (pt) | Tetra-hidronaftalenos substituidos e compostos analogos | |
| ATE429450T1 (de) | Chimärische dr4 antikörper und ihre verwendung | |
| DE69530933D1 (de) | Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis | |
| ATE234812T1 (de) | Integrin antagonisten | |
| ATE525480T1 (de) | Verwendung von a33-antigenen und jam-it | |
| ATE209909T1 (de) | Verwendung von tachykinin-antagonisten zur behandlung von erbrechen | |
| DE69934998D1 (de) | Antisense modulation der expression von integrin alpha 4 | |
| BRPI0503397A (pt) | composição de coloração, processo de coloração e uso de uma composição | |
| DE602004031458D1 (de) | Verfahren zur erhöhung der refinerproduktionsrate und/oder verringerung der spezifischen energie des aufschliessens von holz | |
| ES2173850T3 (es) | Composicion cosmetica y su utilizacion como mascarilla de limpieza de la piel. | |
| DE60239467D1 (de) | Von dd 3b6/22 abgeleitete humanisierte antikörper mit spezifität für das d-dimer fragment von fibrin | |
| MX9101958A (es) | Inhibidores de acat de urea de aminosulfonilo | |
| ATE319997T1 (de) | Screeningverfahren für modulatoren von integrinen | |
| SE9604582D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |